Lupus nephritis: current update

被引：122

作者：

Saxena, Ramesh ^{[1
]}

Mahajan, Tina ^{[1
]}

Mohan, Chandra ^{[1
]}

机构：

[1] UT SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA

来源：

ARTHRITIS RESEARCH & THERAPY | 2011年 / 13卷 / 05期

关键词：

MONOCYTE CHEMOATTRACTANT PROTEIN-1; MIGRATION INHIBITORY FACTOR; PLASMACYTOID DENDRITIC CELLS; INTRINSIC RENAL-CELLS; ANTI-CD4; MONOCLONAL-ANTIBODY; CYTOKINE GENE-EXPRESSION; TH1; IMMUNE-RESPONSE; GROWTH-FACTOR-BETA; T-CELLS; MYCOPHENOLATE-MOFETIL;

D O I：

10.1186/ar3378

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Lupus nephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus. The general consensus is that 60% of lupus patients will develop clinically relevant nephritis at some time in the course of their illness. Prompt recognition and treatment of renal disease is important, as early response to therapy is correlated with better outcome. The present review summarizes our current understanding of the pathogenic mechanisms underlying lupus nephritis and how the disease is currently diagnosed and treated.

引用

页数：12

共 50 条

[41] Lupus Nephritis: Current Perspectives and Moving Forward
Lichtnekert, Julia
Anders, Hans-Joachim
Lech, Maciej
JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 6533 - 6552
[42] Pregnancy and renal outcomes in lupus nephritis: an update and guide to management
Bramham, K.
Soh, M. C.
Nelson-Piercy, C.
LUPUS, 2012, 21 (12) : 1271 - 1283
[43] Update on the management of lupus nephritis: let the treatment fit the patient
Bertsias, George
Boumpas, Dimitrios T.
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (09): : 464 - 472
[44] Lupus nephritis: update on mechanisms of systemic autoimmunity and kidney immunopathology
Lorenz, Georg
Desai, Jyaysi
Anders, Hans-Joachim
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (03): : 211 - 217
[45] Update on the management of lupus nephritis: let the treatment fit the patient
George Bertsias
Dimitrios T Boumpas
Nature Clinical Practice Rheumatology, 2008, 4 : 464 - 472
[46] Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence
Manuel Ramos-Casals
Candido Diaz-Lagares
Maria-Jose Soto-Cardenas
Pilar Brito-Zeron
María-José Cuadrado
Giovanni Sanna
Laura Bertolaccini
Munther A. Khamashta
Clinical Reviews in Allergy & Immunology, 2011, 40 : 159 - 169
[47] Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare
Isabelle Ayoub
Dan Birmingham
Brad Rovin
Lee Hebert
Current Rheumatology Reports, 2019, 21
[48] Lupus Nephritis: Current Treatment Paradigm and Unmet Needs
Menez, Steven P.
El Essawy, Basset
Atta, Mohamed G.
REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (02) : 105 - 113
[49] Treatment of lupus nephritis: current paradigms and emerging strategies
Dall'Era, Maria
CURRENT OPINION IN RHEUMATOLOGY, 2017, 29 (03) : 241 - 247
[50] Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence
Ramos-Casals, Manuel
Diaz-Lagares, Candido
Soto-Cardenas, Maria-Jose
Brito-Zeron, Pilar
Cuadrado, Maria-Jose
Sanna, Giovanni
Bertolaccini, Laura
Khamashta, Munther A.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2011, 40 (03) : 159 - 169

← 1 2 3 4 5 →